Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
Status:
Active, not recruiting
Trial end date:
2023-09-08
Target enrollment:
Participant gender:
Summary
This phase II trial studies phenelzine sulfate in treating patients with prostate cancer that
has not spread to other parts of the body and has come back. Phenelzine sulfate is a type of
antidepressant that works by decreasing the amount of a protein called monoamine oxidase
(MAO). MAO drugs may have an anticancer effect in prostate cancer.